Characterisation of human kallikrein 6/protease M expression in ovarian cancer (original) (raw)
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
Manfred Schmitt
Biological Chemistry, 2000
View PDFchevron_right
Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
Stefania Bellone
Clinical Cancer Research, 2005
View PDFchevron_right
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
diane kowalski
Annals of Oncology, 2008
View PDFchevron_right
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: A new independent unfavourable prognostic biomarker
M. Massobrio
British Journal of Cancer, 2002
View PDFchevron_right
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis
Ulf-Håkan Stenman
Cancer research, 2003
View PDFchevron_right
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model
David Pépin, Zahra Sharif, Geneviève Huppé, Barbara Vanderhyden
PloS one, 2011
View PDFchevron_right
Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols
M. Massobrio
Clinical Chemistry, 2006
View PDFchevron_right
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer – A Pilot Study
Barry Rosen
Tumor Biology, 2006
View PDFchevron_right
Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas
Simon Chu
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
View PDFchevron_right
The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry
Sheila P Little
Journal of Histochemistry & Cytochemistry, 2001
View PDFchevron_right
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients
Riccardo Arisio
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
View PDFchevron_right
Kallikrein 4 Expression Is Up-Regulated in Epithelial Ovarian Carcinoma Cells in Effusions
fahry ann
American Journal of Clinical Pathology, 2005
View PDFchevron_right
Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker
Eleftherios Diam
Journal of Clinical Oncology, 2004
View PDFchevron_right
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma
Maroulio Talieri
Thrombosis and Haemostasis, 2003
View PDFchevron_right
Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer 3
Fred C. G. J. Sweep
Clinical Chemistry, 2006
View PDFchevron_right
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker
M. Massobrio
Cancer research, 2001
View PDFchevron_right
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
Michela Palmieri
American Journal of Obstetrics and Gynecology, 2006
View PDFchevron_right
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
Sheila P Little
Clinical Biochemistry, 2000
View PDFchevron_right
Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma
Nicole Urban
Clinical Cancer Research, 2007
View PDFchevron_right
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
Jeremy A . Squire
Molecular Oncology, 2008
View PDFchevron_right
Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer
Viktor Magdolen
2000
View PDFchevron_right
Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma
MICHAEL VASLAMATZIS
Tumor Biology, 2006
View PDFchevron_right
Integrated genomic characterization of the kallikrein gene locus in cancer.
H. H.
2012
View PDFchevron_right
Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
Hariyono Winarto
View PDFchevron_right
Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas
carlos figueroa
Journal of Cancer Research and Clinical Oncology, 1995
View PDFchevron_right
Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
Nancy Ahmed
Biological chemistry, 2016
View PDFchevron_right
Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients
Fred C. G. J. Sweep
Biological Chemistry, 2012
View PDFchevron_right